Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-004778-16Phase 2Terminated
Phase 2, open-label trial of carfilzomib, lenalidomide and dexamethasone in multiple myeloma (MM) (2 arms), sponsored by Ordensklinikum Linz. Started Dec 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-004778-16.